Impact of facility type and volume on survival in patients with metastatic renal cell carcinoma

CONCLUSIONS: Treatment at ACs and HVHs was associated with a survival benefit in patients with mRCC. Patients treated at AC were more likely to receive immunotherapy, undergo CN and metastasectomy.PMID:34657653

Source: Canadian Journal of Urology - October 18, 2021 Category: Urology & Nephrology Authors: Furkan Dursun Ahmed Elshabrawy Hanzhang Wang James Oelsen Michael Liss Dharam Kaushik Chethan Ramamurthy Ronald Rodriguez Ahmed M Mansour Source Type: research